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Human respiratory syncytial virus (HRSV) is an enveloped RNA virus that assembles and buds from the plasma membrane of
infected cells. The ribonucleoprotein complex (RNP) must associate with the viral matrix protein and glycoproteins to form
newly infectious particles prior to budding. The viral proteins involved in HRSV assembly and egress are mostly unexplored.
We investigated whether the glycoproteins of HRSV were involved in the late stages of viral replication by utilizing recombinant
viruses where each individual glycoprotein gene was deleted and replaced with a reporter gene to maintain wild-type levels of gene
expression. These engineered viruses allowed us to study the roles of the glycoproteins in assembly and budding in the context
of infectious virus. Microscopy data showed that the F glycoprotein was involved in the localization of the glycoproteins with
the other viral proteins at the plasma membrane. Biochemical analyses showed that deletion of the F and G proteins aﬀected
incorporation of the other viral proteins into budded virions. However, eﬃcient viral release was unaﬀected by the deletion of
any of the glycoproteins individually or in concert. These studies attribute a novel role to the F and G proteins in viral protein
localization and assembly.
1.Introduction
Human respiratory syncytial virus (HRSV) is the leading
viral cause of serious pediatric respiratory tract disease
worldwide and a common cause of morbidity in the elderly
[1, 2]. Currently there is no vaccine available and the
only treatment is a monoclonal antibody given to high-
risk infants [3]. Research into vaccine development and
therapeutic design is ongoing but an obvious hurdle is the
lackofacompleteunderstandingofthereplicationcycle.The
roleofthe individual viralgeneproductsineach stepofvirus
replication, particularly in the assembly and release of viral
particles, is unclear.
HRSV, a member of the Paramyxoviridae family, has
a negative-sense, single-stranded RNA genome of 15,222
nucleotides. The genome contains ten genes encoding eleven
known gene products. The viral ribonucleoprotein (RNP)
consists of the RNA genome encapsidated by the nucleo-
protein (N), having associated the phosphoprotein (P) and
RNA-dependent RNA polymerase (L) [4, 5]a sw e l la st h e
M2-1 protein, which is involved in transcription processivity
[6]. The viral genome also encodes the structural matrix
protein (M) [7] and three transmembrane glycoproteins
that are presented on the surface of the viral particle, the
small hydrophobic glycoprotein (SH) [8], the attachment
glycoprotein (G) [9], and the fusion glycoprotein (F) [10].
The major identiﬁed function for the glycoproteins is in
viral entry. The F protein is required for fusion between the
cellular and viral membranes [11], thus allowing the viral
genome to enter the host cell cytoplasm. The G protein is
involved in host cell attachment [12] and is necessary for
infectivity in vivo a n di ns o m ec u l t u r e dc e l lt y p e sw h i l ei n
others its deletion has no eﬀect on infectivity [13]. The role
oftheSHproteinisstillunclear,althoughithasrecentlybeen
found to inhibit apoptosis [14, 15]. The viral glycoproteins
along with the M, N, P, L, and M2 proteins are essential
structural and enzymatic components of HRSV. How these
viral components assemble to form a newly infectious virion
and how the release of the virus from the host cell is
coordinated is largely unknown.2 Advances in Virology
HRSVassemblesatandbudsfromtheplasmamembrane
of the infected cell to gain its envelope [16–18]. For many
paramyxoviruses, it has been shown that the M protein
is suﬃcient for particle release, and in some cases the F
glycoproteinhasbeenshowntoenhancetheprocess[19–24].
In other instances, such as for SV5, viral budding requires
the M protein, one of its two viral glycoproteins, and the
Np r o t e i n[ 25]. These studies used transient transfection
systems to additively express individual viral proteins and
analyzed their eﬀects on the amount of released virus-like
particles (VLPs). A similar study done with HRSV found
the M, P, N, and F proteins to be the minimal requirements
for formation and passage of VLPs containing minigenomes
[26]. However, this study did not look speciﬁcally at the
release of the VLPs; therefore it is still unclear whether the
F protein is needed only for viral entry or for entry and
subsequent steps leading to VLP passage.
Previously, we examined the eﬀect of HRSV glycoprotein
deletionsonthedirectionaltargetingofthevirusinpolarized
epithelial cells [27]. This earlier study was a qualitative inves-
tigation which demonstrated that HRSV particles are able to
bud directionally in the absence of all three glycoproteins.
However, a quantitative analysis of the contribution of these
viral proteins to the late stages of viral protein traﬃcking,
assembly, and release was not done. In the present study,
the role of the three viral glycoproteins in viral assembly
and egress from infected cells was examined. First, the
contribution of each glycoprotein to viral assembly was
analyzed by investigating the localization of the remaining
viralstructuralproteinsattheplasmamembranebyconfocal
microscopy. Next, the protein composition of particles
released from cells infected with WT or glycoprotein deleted
HRSV was biochemically quantitated to determine if one
or more glycoproteins are involved in the incorporation of
viral proteins into newly formed viral particles. Finally, the
eﬀect of each glycoprotein on the eﬃciency of virus particle
budding from infected cells was analyzed.
2. Results
2.1. Engineered Viruses. To examine the involvement of each
glycoprotein in the assembly and release of HRSV, we used
viruses previously engineered to have each glycoprotein gene
deleted individually from the HRSV genome and its ORF
replaced with that of a reporter gene (Figure 1)[ 27]. We
also utilized an engineered virus with all three glycoprotein
genes deleted [27]. Since HRSV transcription is obligatorily
sequential and due to attenuation at each gene junction, the
replacement of any deleted genes was necessary to maintain
authentic levels of viral gene expression. Brieﬂy, in the case
of individual deletions, GFP was used to replace the deleted
gene. When three genes, SH, G, and F, were deleted they were
replaced respectively with the GFP, CAT, and GUS, reporter
genes (Figure 1). All of the viruses described above not only
maintained the same number of genes as in WT HRSV
but also had the genuine intergenic junctions to preserve
authentic transcription levels.
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Figure 1: Schematic of the gene content of engineered viruses. All
engineered viruses were generated from a cDNA of the A2 strain of
HRSV. Viruses RSΔSH, RSΔG, and RSΔF are missing the ORFs of
the SH, G, and F genes, respectively, which have been substituted
with that of GFP. Virus RSΔSH,G,F has the ORFs encoding each of
the three HSRV glycoproteins replaced with those of reporter genes
GFP, CAT, and GUS, respectively.
2.2. Eﬀect of Single Glycoprotein Deletions on the Intracellular
Localization of HRSV Proteins at the Site of Viral Assembly.
The HRSV proteins must assemble at the plasma membrane
to initiate budding of the RNP to form newly enveloped
and infectious viral particles upon release from the cell.
In polarized epithelial cells, this process takes place on
the apical membrane [18]. We previously demonstrated
that the glycoproteins are not involved in the directional
targeting of the viral proteins for viral release from the apical
membrane to occur [27]. However, the techniques used in
this prior study did not analyze the eﬀects of individual
glycoprotein gene deletions on intracellular assembly with
other viral proteins. To address this question, the level of
colocalization at the plasma membrane of each of the three
glycoproteinswiththeNprotein,whichwasusedasamarker
for ribonucleocapsids, was analyzed by microscopy.
A549 cells were infected with WT or individual gly-
coprotein deleted viruses at a MOI of 0.2. Twenty-four
hours after infection the cells were ﬁxed, permeabilized, and
incubated with primary antibodies against N, and SH, or G,
or F proteins in turn and followed by secondary antibodies
conjugated to AlexaFluor 647 and 594 ﬂuorescent dyes.
A confocal microscope was used to take multiple z plane
images (z-stacks) through the cell as described in Section 4.
Since viral assembly takes place at the plasma membrane we
focused on the z-stack containing that section of the infected
cell, which is shown in all images and is depicted in the
diagram in Figure 2(a). In Figures 2(b), 2(c),a n d2(d) the
N protein is shown in green with the three glycoproteins, in
individual panels, shown in red (F and N staining is shown
in Figure 2(b), G and N staining is shown in Figure 2(c),
and SH and N staining is shown in Figure 2(d)). A merge
panel of the two stained proteins is also shown along with
a magniﬁcation of the merge to further demonstrate the
colocalization in each image. Also shown within each mergeAdvances in Virology 3
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Figure 2: Eﬀect of the deletion of individual glycoprotein genes on colocalization of the HRSV nucleocapsid protein with each glycoprotein
at the plasma membrane. (a) A diagram of an infected cell depicting HRSV assembly at the plasma membrane. The boxed area represents
the 1µm z-stack shown in subsequent confocal microscope images. The nucleus is depicted as a blue circle. A549 cells infected with WT or
glycoprotein deleted HRSV at a MOI of 0.2 were ﬁxed, permeabilized, and incubated with an anti-N antibody and an anti-F antibody (b), an
anti-G antibody (c), or an anti-SH antibody (d). The glycoprotein stains are shown in the left row (red), the N protein stains in the middle
row (green), and a merge of the two stains in the right row. A blowup of the merge is also shown. Images were taken on a Zeiss confocal
microscope. An average of fourteen cells were imaged per staining, and colocalization was measured using ImageJ JACoP plugin. Pearson’s
coeﬃcient ± standard error of mean is shown within the merge panels.
panel is the amount of colocalization quantitated by NIH
ImageJ software [28] and is depicted as Pearson’s coeﬃcient
[29], where a number near +1 suggests perfect correlation
between two biomolecules, a number near 0 indicates no
correlation, and a number near −1 suggests an inverse
correlation or exclusion of the biomolecules.
An average of fourteen cells were imaged per staining,
and their average Pearson’s coeﬃcient was quantitated along
with the standard error of the mean (SEM). As shown in
Figure 2(b), similar levels of colocalization were observed
betweentheNandFproteinsincellsinfectedwithWT,ΔSH,
and ΔG viruses (Pearson’s coeﬃcients of 0.26, 0.38, and 0.33,
resp.)suggestingthattheSHandGproteinsarenotnecessary
for the assembly of the remaining glycoproteins and the
RNPs at the cell surface. In Figure 2(c) similar amounts of
colocalization between the N and G proteins were observed
in cells infected with WT and ΔSH viruses (Pearson’s
coeﬃcient of 0.42 and 0.40, resp.) whereas a ninefold
decrease in colocalization between the N and G proteins was
observed in cells infected with ΔFvi r u s( P e a r s o n ’ sc o e ﬃcient
of0.05).ThisindicatedthatFisinvolvedinthecolocalization
of the N and G proteins at the cell surface. In addition,4 Advances in Virology
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Figure 3: Eﬀect of the deletion of individual glycoprotein genes on the colocalization of pairs of HRSV glycoproteins at the plasma
membrane. Localization of HRSV glycoproteins at the site of viral assembly by confocal microscopy. A549 cells infected with WT or
glycoprotein deleted HRSV as indicated at a MOI 0.2 were ﬁxed, permeabilized, and incubated with primary antibodies against two diﬀerent
glycoproteins. (a) Staining of F and G glycoproteins where F is shown in red and G in green. (b) Staining of SH and F where SH is shown in
red and F in green. (c) Staining of SH and G where SH is shown in red and G in green. A merge of the two stains is shown in the right row. A
blowup of the merge is also shown. Images were taken on a Zeiss confocal microscope. An average of twelve cells were imaged per staining,
and colocalization was measured using ImageJ and JACoP plugin. Pearson’s coeﬃcient ± standard error of mean is shown within the merge
panels.
the distribution of the G protein at the plasma membrane
diﬀered in cells infected with ΔF virus as compared to
cells infected with WT or ΔSH viruses. In the absence of
the F glycoprotein, G protein had a more monodisperse
distribution rather than the ﬁlamentous forms seen in WT-
infected cells (cf. Figure 2(c), cells infected with WT virus
and ΔF virus). Colocalization was observed between the
N and SH proteins in cells infected with WT virus, albeit
at a relatively low level (Figure 2(d);P e a r s o n ’ sc o e ﬃcient
of 0.19). A slightly increased but similarly low level of
colocalization between the N and SH proteins was seen in
cells infected with ΔGv i r u s( P e a r s o n ’ sc o e ﬃcient of 0.28). In
cells infected with the ΔF virus, however, colocalization was
seen at approximately half of WT levels (Pearson’s coeﬃcient
of 0.11). Thus, the above results show that the absence of the
Fp r o t e i na ﬀects the colocalization of the G protein with the
N protein at the plasma membrane and, to a lesser extent,
that the absence of the F protein aﬀects the colocalization of
the SH protein with the N protein at the plasma membrane.
Next, we examined the eﬀect of deletions of individual
glycoproteins on the levels of colocalization between the
remaining two glycoproteins at the plasma membrane by
microscopy. A549 cells infected with WT or engineered
viruses were ﬁxed and permeabilized and then incubated
with primary antibodies against two of the glycoproteins. In
Figure 3(a), the F glycoprotein is shown in red and the G
protein is shown in green. In Figures 3(b) and 3(c), the SH
glycoprotein is shown in red while the F and G proteins are
shown in green, respectively. In each case a merge panel of
the two proteins is also shown along with a magniﬁcation
of the merge to further illustrate the extent of colocalization
in each image. Also shown within the merge panel is the
amount of colocalization depicted as Pearson’s coeﬃcient as
describedforFigure 2. An averageof twelve cells wereimaged
per staining, and their colocalization is shown along with the
standard error of the mean (SEM).
High levels of colocalization were observed between the
F and G glycoproteins in cells infected with WT virus
(Figure 3(a);P e a r s o n ’ sc o e ﬃcient of 0.77), and deletion of
the SH gene did not aﬀect F and G protein colocalization
(Figure 3(a);P e a r s o n ’ sc o e ﬃcient of 0.76). Colocalization
between the SH and F proteins in WT- or ΔG-infected cells
was observed at relatively low levels (Pearson’s coeﬃcient ofAdvances in Virology 5
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Figure 4: Eﬀect of deletion of glycoprotein genes on the incorporation of HRSV proteins into released viral particles. Twenty-four hours
after infection, A549 cells infected with WT or glycoprotein deleted HRSV at a MOI of 1.0 were radiolabeled with 35SC y s / M e tf o r1 6h .
The supernatant containing the released viral particles was collected, cleared of cell debris, and concentrated by centrifugation. (a) The
viral pellet was resuspended, and viral proteins were immunoprecipitated with a polyclonal anti-HRSV antibody along with monoclonal
antibodies against G and SH. Proteins were analyzed by electrophoresis on a 12% SDS polyacrylamide gel. A representative gel is shown.
The bar graph depicts ratios of each HRSV structural protein to N protein, normalized to the ratios found in WT viral particles. (b) Infected
cells were lysed and viral proteins were immunoprecipitated with a polyclonal anti-HRSV antibody along with antibodies against G and SH.
Proteins were analyzed on a 12% SDS-PAGE. A representative gel is shown. The bar graph depicts ratios of each HRSV structural protein
to N protein, normalized to the ratios found in WT-infected lysate. Proteins were quantitated on a phosphorImager. Error bars represent
standard deviation from at least three experiments.
0.15 and 0.29, resp.; Figure 3(b)). Low amounts of colocal-
ization were also observed between the SH and G proteins
in WT- and in ΔF-infected cells (Pearson’s coeﬃcient of
0.10 and 0.13, resp.; Figure 3(c)). Taken together these data
indicatethatdeletionofanysingleglycoproteindidnotaﬀect
the localization of the other two glycoproteins. Further, these
data show the F and G glycoproteins colocalize substantially;
however, SH does not colocalize with either F or G proteins
to a high degree.
2.3. Eﬀect of HRSV Glycoprotein Deletions on the Incor-
poration of Viral Proteins into Newly Budded Virions. To
further scrutinize a potential role for HRSV glycoproteins
in the late stages of the viral replication cycle, released
particles were biochemically analyzed for their viral protein
composition. A549 cells were infected with WT or glyco-
protein deleted HRSV at a MOI of 1.0. Twenty-four hours
after infection the cells were radiolabeled with 35SC y s / M e t
for 16h. The supernatant containing the released virions
was collected and concentrated by centrifugation. The viral
proteins present in the pelleted virions were analyzed by
immunoprecipitation followed by SDS polyacrylamide gel
electrophoresis as described in Section 4. The ratio of the
HRSV structural proteins, M, F, G, and SH relative to the
N protein was determined. The ratios found in glycoprotein
deleted viral particles were compared to those found in WT
viral particles (Figure 4(a)). The F glycoprotein is translated
as the precursor protein F0 and then cleaved into F1 and F2.
The cleaved product F1 was labeled most eﬃciently by 35S
Cys/Met, and so we quantiﬁed this protein to represent F.
As shown in Figure 4(a) when cells were infected with the
ΔSH virus no substantial diﬀerences in the incorporation of6 Advances in Virology
the M, G, or F proteins into viral particles were observed
when compared to WT particles. Cells infected with the ΔG
virus had WT-like levels of the M and F proteins in released
virions; however, the amount of SH protein incorporation
was decreased to approximately 40% of that found in WT
viral particles. Virus released from ΔF-infected A549 cells
had slightly decreased levels of the M protein, at 70% of
that found in WT virus. The most dramatic diﬀerences in
particles released from ΔF-infected cells were observed in the
amounts of incorporated SH and G proteins, which were
reduced to 25% and 30% of WT levels, respectively. Cells
infected with the ΔSH,G,F virus had WT-like amounts of M
protein incorporation.
Although all engineered viruses containing glycoprotein
deletionshadreplacementreportergenestoensureWTlevels
of transcription of the downstream genes [30], viral protein
levels in cells infected with the engineered viruses were also
analyzed to determine whether the levels of protein synthesis
were aﬀectedby the deletion ofthe glycoproteins. Toconﬁrm
that the protein incorporation defects observed in budded
viral particles were not due to decreased amounts of those
viral proteins in infected cells, the HRSV structural proteins
in infected cell lysates were also quantitated and reported as
a ratio to the N protein. As shown in Figure 4(b), the ratios
of the M, SH, and F proteins to the N protein in cell lysates
infected with glycoprotein deleted viruses were equivalent to
or greater than those found in WT-virus-infected cell lysate.
These data indicated that the eﬀe c to fGa n dFg l y c o p r o t e i n
deletions on decreased SH incorporation into particles was
not due to overall reduction in SH protein synthesis.
We used A549 cells in these studies because infectivity
experiments performed in diﬀerent cell types showed that
the ΔF virus, which utilizes GP64 for viral entry [31] did not
give a productive infection in HEp2 cells (see supplementary
Figure1(a) in Supplementary Material available online at
doi:10.1155/2011/343408).WefoundthatA549cellsallowed
for more robust infection of ΔF viruses than HEp2 and
Vbac cells [32] (supplementary Figure1(a)). In contrast, the
ΔSH virus had equivalent levels of infection in all cell types
tested (supplementary Figure1(b)). However, in A549 cells
the quantitative detection of a discrete band of a mature
84kDGproteineveninWT-infectedcelllysateswasdiﬃcult.
We suspect, in A549 cells, that the heterodisperse nature of
the extensive O-linked glycosylation and the low methionine
content of G protein prevent detection of a discrete band.
However, previous work showed that gene transcription
levels were not altered in the glycoprotein deleted viruses
[30], and we know from the microscopy data in this study
that the amount of the G protein stainings in WT- and
in ΔF-infected A549 cells were comparable (Figures 2(c)
and 3(c)). As such, although we were unable to conﬁrm
equivalent G-to-N-protein ratios in cell lysates infected with
glycoprotein deleted viruses as compared to WT-infected
cell lysates (Figure 4(b)), data strongly suggests that the G
protein synthesis was unaﬀected by the deletion of the F
glycoprotein.
2.4. Involvement of HRSV Glycoproteins in Viral Release.
Since we observed a role for the glycoproteins in viral
assembly, we asked if they were also involved in the other
late stage of the replication cycle, viral release. We knew
from our previous work that the glycoproteins were not
required for viral release [27], but those studies had not
quantitatively examined the eﬀect of glycoprotein deletions
on the eﬃciency of viral budding. To address this question,
weinfectedA549cellswitheitherWTorglycoproteindeleted
virus and quantiﬁed the amount of particles released as a
percent of total virus produced in cells. In infected cells
the N protein will either associate with the viral genome to
form RNPs and localize to the plasma membrane for viral
assembly or remain in the cytoplasm as a soluble protein.
To quantify HRSV production and viral release, we only
considered the N protein bound to RNPs since this is the
form that assembles into viral particles and buds from the
plasma membrane. Therefore our ﬁrst step was to separate
N protein in RNPs from free soluble N protein in infected
cell lysates as a measure of virus inside the cell. Infected
A549 cells were radiolabeled with 35S Cys/Met and lysed as
described in Section 4. The lysate was layered on top of a
40% glycerol cushion and ultracentrifuged as described in
Section 4. Fractions were taken from the top of the tube
(fraction 1) to the bottom of the tube (fraction 4), and the
pellet was resuspended in lysis buﬀer. HRSV proteins in each
fraction were identiﬁed by immunoprecipitation followed
by analysis on 12% SDS polyacrylamide gel as described in
Section 4. As shown in Figure 5(a), soluble proteins such as
G, F1, N, P, M, and SH were found in fractions 1–4 whereas
predominantly proteins bound to the viral genome, L, N, P,
and M2-1, were found in the pellet.
To quantify the amount of virus released from infected
cells, A549 cells were infected with WT or glycoprotein
deleted viruses at a MOI of 1.0. Twenty-four hours after
infection the cells were radiolabeled with 35SC y s / M e t .
Supernatants containing released virions were collected and
concentrated by centrifugation, as described previously in
[27] and in Section 4. Pelleted virions were disrupted and
HRSV proteins were identiﬁed by immunoprecipitation
followed by analysis by polyacrylamide gel electrophoresis.
The infected cells were also lysed and RNPs separated by
glycerol sedimentation as described above. The RNP bound
N protein present in pelleted virions and in infected cell
lysates was analyzed on SDS gels and quantitated. The
amount of N protein present in released virus is shown as
a percent of total N protein in RNPs quantiﬁed from both
lysate and virus (Figures 5(b) and 5(c)). Cells infected with
ΔSH, ΔG, ΔF viruses, or the triple deletion virus ΔSH,G,F,
did not show any decrease in the levels of released viral
particles compared with cells infected with WT virus. These
ﬁndings show that the viral glycoproteins do not negatively
aﬀect the eﬃciency of viral egress.
3. Discussion
The major HRSV structural proteins are the nucleocapsid
protein (N), the matrix (M) protein, and the F, G, and
SH glycoproteins, all of which associate at the plasma
membrane for viral assembly and release. Little is known
about the protein requirements of HRSV during the lateAdvances in Virology 7
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Figure 5:Eﬀectofglycoprotein deletions onthereleaseofvirionsfrominfected A549cells. A549cellswere infected with WTorglycoprotein
deleted virus and particles released into the supernatant were quantiﬁed as a percent of total virus produced. The N protein in isolated RNPs
wasusedtoquantitatethevirusincelllysatesandinvirions.(a)SeparationofRNPscontainingtheviralgenomeandassociatedproteinsfrom
soluble proteins in infected cell lysates. Infected cell lysates were ultracentrifuged through a 40% glycerol cushion. Fractions were taken from
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Viral proteins in each fraction and the pellet were immunoprecipitated and analyzed on a 12% SDS polyacrylamide gel. A representative gel
is shown. HRSV proteins are indicated on the right of the gel. (b) Ribonucleoprotein (RNP) associated N protein in infected cell lysates was
harvested as described above and in Section 4, and viral proteins were analyzed by immunoprecipitation and electrophoresis on 12% SDS
gels. Released virions were recovered from supernatant ﬂuids by centrifugation and viral proteins were analyzed by immunoprecipitation
andelectrophoresison12%SDSgels.Arepresentativegelisshown.(c)BargraphdepictsthepercentofNproteinquantiﬁedinreleasedvirus
from total RNP-associated N protein quantiﬁed in infected cell lysate and in released virus. The N protein was quantitated by phosphoimage
analysis. Error bars represent standard deviation from at least three experiments.
stage of virus replication. It has been established for many
paramyxoviruses that the M protein is necessary for the
formation of viral particles [19–25], but the involvement
of the glycoproteins varies depending upon the virus. The
HRSV glycoproteins have deﬁned roles in attachment and
entry,butdelineating theirpotential rolesin thedownstream
steps of the replication cycle is diﬃcult due to the necessity
of the F protein for viral entry into cells.
In this study we utilized genetically engineered HRSV in
which one or more of the glycoprotein genes were deleted
a n dr e p l a c e dw i t hr e p o r t e rg e n e s( Figure 1). Recombinant
viruses lacking the F protein were used in conjunction with
a cell line that expresses GP64 to overcome the inherent viral
entry deﬁcit of a F deleted virus [32]. In a previous study
using these engineered viruses we showed that HRSV with
all three glycoprotein genes deleted released viral particles8 Advances in Virology
speciﬁcally from the apical membrane of polarized epithelial
cells [27], which conﬁrmed that the glycoproteins were
not essential for directional targeting or for viral release.
However, we did not address whether the glycoproteins
aﬀected the quantitative eﬃciency of viral egress or whether
the glycoproteins were involved in the assembly of the
other viral proteins at the plasma membrane to form newly
infectious viral particles.
Priortoviralbuddingfrominfectedcells,thethreeHRSV
glycoproteins must assemble with the RNPs at the plasma
membrane. To determine if the individual glycoproteins are
involved in the assembly of the other structural proteins,
we studied cells infected with viruses having individual
glycoprotein genes deleted and examined the colocalization
of the remaining glycoproteins at the plasma membrane by
confocal microscopy. We observed that the deletion of any
individual glycoprotein did not aﬀect the colocalization of
the remaining glycoproteins at the cell surface (Figure 3).
Using the N protein as a marker for RNPs, we also
investigated whether deletion of the individual glycoproteins
aﬀected the assembly of the remaining glycoproteins and the
N protein at the plasma membrane. We found that deletion
of the F glycoprotein substantially reduced the colocalization
of the G protein with the N protein at the plasma membrane.
DeletionoftheFproteinalsoreducedcolocalizationbetween
the SH and N proteins at the cell surface (Figures 2(c) and
2(d), resp.). These data indicate that F protein plays a previ-
ously unidentiﬁed role in localizing virus structural proteins
during HRSV assembly. Interestingly, we also observed in
ΔF-virus-infected cells that the staining pattern of G protein
on the plasma membrane was altered as compared to WT-
virus-infected cells (Figure 2(c), compare G staining in WT-
infected cell with that in ΔF-infected cell). These ﬁndings are
consistent with results from a previous study which showed
that the G glycoprotein localized to viral ﬁlaments at the
plasma membrane in cells infected with WT virus, but not in
cells infected with an engineered HRSV with the cytoplasmic
tail of F protein deleted (FΔCT) [33], further suggesting that
the F protein is involved in protein sorting at the cell surface.
Once the viral proteins have assembled at the cell surface,
they are incorporated into newly formed virus particles as
RNPs bud from the plasma membrane. We analyzed whether
deletionofeachindividualglycoproteinaﬀectedtheabilityof
theremainingstructuralproteinstoincorporateintobudded
virions. We found that cells infected with viruses lacking
the F glycoprotein incorporated decreased amounts of the
G and SH proteins relative to the N protein in released
virus (Figure 4(a)). These ﬁndings are in agreement with
the previous observation that the deletion of the F protein
resulted in decreased amounts of colocalization between
RNPs and both the G and SH proteins at the cell surface
(Figures 2(c) and 2(d), resp.). Cells infected with viruses
lackingtheGproteinalsoincorporatedloweramountsofthe
SH protein into released virions (Figure 4(a)). These results
indicate that the F and G glycoproteins are involved in HRSV
particle assembly.
We used two approaches, microscopy and protein
biochemistry, to investigate the eﬀect of the glycoprotein
deletions on viral assembly. These two methods further
dissected the assembly process into two separate steps: the
accumulation of viral proteins at the plasma membrane,
which is the site of viral assembly, and the incorporation
of the accumulating proteins into budding viral particles.
BothexperimentsconcludedthatSHisnotinvolvedineither
stage of viral assembly as WT-like levels of colocalization
were observed between the remaining structural proteins at
the plasma membrane of ΔSH-infected cells, and WT-like
levels of HRSV proteins were found in released particles.
Both the microscopy and the biochemical data indicated
that F glycoprotein is involved in both steps of the assembly
process as colocalization between the N and SH proteins
and between the N and G proteins in ΔF-infected cells was
decreased as compared to WT-infected cells. Cells infected
with ΔF virus also had decreased amounts of the G and
SH proteins incorporated into budded virions as compared
to WT particles. The G glycoprotein does not appear to be
implicatedintheaccumulationofviralproteinsattheplasma
membrane since WT and elevated levels of colocalization
were observed between the N, SH, and F proteins in cells
infected with ΔG virus. However, the G protein was involved
in the incorporation of the SH protein into the budding
virion as shown by a decrease in the SH-to-N-protein ratio
in particles released from ΔG-infected cells as compared to
WT virions. The reasons for this dichotomy are unknown.
The SH protein exists in several modiﬁed and unmodiﬁed
forms including its modiﬁcation by polylactosaminoglycans,
and these forms as well as the unmodiﬁed form are found
in virions [34]. It would be of interest to determine whether
there may be interactions between one or more of the
modiﬁed forms of SH and the highly O glycosylated G
protein. The M protein was incorporated at near WT-like
levels in all glycoprotein deleted viruses, including the triple
deleted virus, indicating that the M protein assembles into
budding virus independently of the glycoproteins.
Theﬁnalsteptoproducenewviralparticlesaftertheviral
proteins have assembled at the plasma membrane is egress
from infected cells. To determine if the viral glycoproteins
were involved in the budding process, we analyzed whether
deletion of the glycoproteins aﬀected the eﬃciency of viral
release. We found that the absence of any or all of the three
glycoproteinsdidnothaveadeleteriouseﬀectontheamount
of virus released from infected cells (Figure 5). Indeed, ΔF-
and ΔG-infected cells released slightly increased amounts
of viral particles into the supernatant as compared to WT
infected cells. We speculate that fewer glycosylated proteins
in the virus led to less reattachment of viral particles to the
cell. This resulted in fewer cell-associated virions and hence
an increase in released viral particles in the supernatant.
Previous studies have shown an interaction between the
SH and G proteins in cells infected with WT HRSV [35]
which may explain the requirement for the G protein in
the incorporation of the SH protein into budding virus.
Interactions have also been shown for the G and M proteins
[36] and for the G and F proteins [37]. An oligomeric
complex was also reported in infected cell lysates between
the F, G, and SH proteins [38]. It has been hypothesized
that the F glycoprotein interacts with other viral proteins via
its cytoplasmic tail (CT), based on a study which showedAdvances in Virology 9
that the ability of the F protein to interact with lipid rafts
at the plasma membrane was disrupted and the localization
of the F and the G proteins at the plasma membrane was
altered when cells were infected with FΔCT virus [33]. These
previous studies along with the data presented here indicate
that the three HRSV glycoproteins interact with other viral
structural proteins in infected cells, and, importantly, this
study attributes a novel role to the F and G glycoproteins in
the late stages of viral replication.
4.MaterialsandMethods
4.1. Cells and Antibodies. A549, Vero, and HEp2 cells were
acquired from the American Type Culture Collection
(ATCC). A549 cells were grown in Ham’s F12K medium
(Sigma Aldrich, St. Louis, Mo) containing 10% fetal bovine
serum, and Vero and HEp2 cells were grown in Dulbecco’s
minimal essential medium (DMEM; Invitrogen, Carlsbad,
Calif) containing 5% fetal bovine serum. Vbac cells (Vero
cells expressing the baculovirus GP64 protein carrying the
HRSV F protein COOH-terminal residues 563 to 573)
were described previously in [32]. Monoclonal antibodies
(MAbs) 19 and 29 were provided by Geraldine Taylor
(Institute for Animal Health, Compton, UK), as was the
bovine polyclonal antibody against all HRSV proteins, R45.
The monoclonal antibody, mAb15, was provided by James
Stott (Institute for Animal Health, Compton, UK). Rabbit
anti-SH antibody was provided by Biao He (University of
Georgia). AlexaFluor-conjugated secondary antibodies were
from Molecular Probes (Carlsbad, Calif).
4.2. Construction of cDNAs and Recovery of Infectious HRSVs.
All cDNAs were constructed from the HRSV A2 strain.
cDNAs engineered to contain glycoprotein gene deletions
for these studies were constructed as described previously
in [27, 30, 33]. Brieﬂy, using standard cloning techniques,
vectors were constructed lacking the G or F transmembrane
glycoprotein open reading frame (ORF) and containing
the EGFP ORF instead, as shown in Figure 1.A l lH R S V
ORFs were maintained in their original genome positions
to maintain expression proﬁles similar to that of a wild-
type virus. For generation of the recombinant wild-type
(WT) virus, the vector contained the authentic SH, G, and
F ORFs and no marker protein ORF. The ORFs contained
in each of the vectors were separated by authentic HRSV
intergenic junctions and ﬂanked by unique restriction sites
FseIa n dAscI. Using matching FseIa n dAscIr e s t r i c t i o n
sites, the vectors were then cloned into an SH/G/F-deleted
cDNA backbone. The engineered cDNAs were screened by
restriction enzyme analysis, and all modiﬁed areas were
veriﬁed by nucleotide sequencing prior to virus recovery.
Infectious viruses were recovered from cDNA as
described previously in [31]. Notably, to relieve selection
pressure that might result from the eﬀect of gene replace-
ments, a plasmid encoding a chimeric VSV G protein was
included in the initial transfection, and Vbac cells were used
for virus ampliﬁcation. Viral RNAs were harvested from cells
infected with the engineered viruses at passage 3, ampliﬁed
byRT-PCR,andthesequenceofselectedareaswasveriﬁedby
bulk nucleotide sequence analysis. No changes were found.
Virus stocks at passages 3 to 5 were used for the experiments
described.
4.3.VirusInfections. InfectionsofcellsbyHRSVwerecarried
o u tb ya d s o r b i n gv i r u st oc e l l sf o r1 . 5 ha t3 3 ◦C, followed
by removing the inoculum and washing the cells once with
growth media and then continuing incubation at 33◦Cf o r
24h or 48h, depending on the assay.
4.4. Immunoﬂuorescence Staining and Confocal Microscopy.
A549 cells were plated on sterile coverslips in 6-well
plates (BD biosciences, San Jose, Calif). Cells were then
infected with engineered viruses at a MOI of 0.2 and
furtherincubatedat33◦C.Twenty-fourhoursafterinfection,
cells were washed twice with PBS and ﬁxed with 3.7%
paraformaldehyde (PFA) in phosphate-buﬀered saline (PBS)
for 15min at room temperature (RT). Cells were washed
twice with PBS, permeabilized with 0.02% triton X-100,
blockedin1%BSAfor10min,andstainedwiththefollowing
primaryantibodiesdilutedin0.1%BSA:FmAb19at1:5000;
G mAb29 at 1:2000; N mAb15 at 1:15000; rabbit anti-
SH at 1:200 for 1h at RT. Cells were washed twice with
PBS, blocked with 1% BSA, and incubated with secondary
antimouse or antirabbit antibodies conjugated to AlexaFluor
594 or 647 (Invitrogen) at a dilution of 1:1000 for 30min at
RT. When costaining with primary antibodies from the same
host, the Apex labeling kit was used (Invitrogen) to directly
conjugate the primary antibody with AlexaFluor 647. Cells
were washed twice with PBS and stained with Hoechst stain
(Molecular Probes) at 0.05mg/mL in PBS. Cells were washed
threetimeswithPBS,mountedonslides,andstoredat4◦Cin
thedark.ImagesweretakenonaZeissLSM510-UVconfocal
microscopeusingthe40xorthe100xobjective.1µmz-stacks
were taken through each cell, and the top plasma membrane
stack was taken to visualize the site of HRSV assembly. The
plasma membrane containing section was identiﬁed as the
most apical stack containing in-focus staining and without
visible nuclear staining.
The ﬂuorescence in the top plasma membrane stack
was quantitated to determine the levels of colocalization
b e t w e e nNa n de a c hg l y c o p r o t e i no rb e t w e e nt w og l y c o p r o -
teins. Quantitation of pixels was done using ImageJ with
JACoP plugin [39]. Thresholds for each wavelength were
determined on JACop using Costes automatic thresholding
[40], and the amount of colocalization of pixels above
the threshold was determined and reported as Pearson’s
coeﬃcient (R) ± standard error of the mean (SEM).
4.5. Viral Assembly and Release Assays. A549 cells were
plated in 60mm dishes (BD biosciences) and incubated at
37◦C. Approximately 6h later, the cells were infected with
engineered viruses at a MOI of 1.0 and incubated at 33◦C.
24h later the cells were radiolabeled using 35SC y s / M e tt r a n s
mix (Promega, Madison, Wis) and incubated at 33◦C. 16h
later the supernatants containing the released virions were
carefully removed from the cell monolayer and put into10 Advances in Virology
2mL tubes. The supernatants were centrifuged at 750×gf o r
4min to pellet any cell debris. The supernatants containing
the viral particles were transferred to a new 1.5mL tube
and centrifuged at 1500×g for 30min, a speed that allows
for the fragile HRSV particles to be concentrated and still
maintain infectivity [27]. We conﬁrmed that this pelleting
method concentrated virions with one glycoprotein or two
glycoproteins deleted to ensure that particles with decreased
density still pelleted at the low speed (data not shown).
The viral pellets were resuspended in 0.1mL lysis buﬀer
consisting of 1% NP40, 0.4% deoxycholic acid, 66mM
EDTA, and 10mM Tris-HCl, pH 7.4. The entire volume
was incubated with the bovine polyclonal antibody R45
at 1:100 dilution + rabbit anti-SH antibody at 1:25 +
anti-G mAb29 at 1:100 overnight at 4◦C. Meanwhile, the
infected cell monolayers were washed once with PBS and
then lysed in lysis buﬀer (described above). The lysates were
harvested into 1.5mL tubes, incubated on ice for 7min,
and vortexed for 30sec. The cell nuclei were removed by
centrifugation at 14,000rpm for 1min. The RNP-associated
proteins were then pelleted by ultracentrifugation through
a 40% glycerol cushion at 190,000×gf o r2 ha t4 ◦C. The
pellets were resuspended in 0.1mL lysis buﬀerand incubated
with R45 antibody at 1:100 dilution overnight at 4◦C. The
next day 25µL of Protein G sepharose (GE Healthcare,
Piscataway, NJ) was added to each lysate + antibody and
released virus + antibody and incubated for at least 1h
at 4◦C. The immunoprecipitations were washed 3x with
wash buﬀer consisting of 1% NP-40, 0.5% DOC, 0.1%
SDS, 150mM NaCl, and 10mM Tris-HCl, pH 7.4, and then
b o i l e df o r3m i ni n2 5µL of 2x reducing Laemmli buﬀer. All
samples were electrophoresed on 12% polyacrylamide gels.
The gels were ﬁxed, dried, and exposed to both ﬁlm and
a phosphorImage screen. Protein amounts were quantiﬁed
from phosphorImage scans on a model 860 STORM scanner
and the ImageQuant software (Molecular Dynamics).
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